REDWOOD CITY, Calif., Oct. 28, 2009 (GLOBE NEWSWIRE) --
News facts:
Proven Enterprise Solution for Global Address Validation
AddressDoctor is used by enterprises worldwide to validate and cleanse international mailing addresses. AddressDoctor increases the accuracy of mailings resulting in time and cost savings in postal service administration -- including reduced postal charges, dispatching and wasted paper. AddressDoctor 5 is a major new release that provides additional new features including:
Quotes:
"In AddressDoctor 5, we have implemented a number of optimizations to offer our customers even better data quality," says Sven Schreiber, AddressDoctor CEO. "The new version also offers significant speed improvements - saving time for our customers. The improved speed also means that data processing can run overnight, making systems fully available during business hours."
Availability of AddressDoctor 5
AddressDoctor 5 is available immediately via web services and on-premise. AddressDoctor 5 is compatible with Windows, Linux and Unix operating systems and supports multiple character sets such as Cyrillic, Japanese and Chinese.
About AddressDoctor:
AddressDoctor GmbH is the leading provider of solutions for checkup and cleansing of international postal data, with more than 10 years experience. In June 2009 the company was acquired by Informatica, the world's number one independent provider of data integration software. AddressDoctor cleanses data from 240 countries and territories, using advanced algorithms and country-specific local knowledge. More than 500 customers worldwide already use AddressDoctor to enhance their data quality, including companies such as 1&1 Internet AG, Kempinski Hotels and MRM Worldwide. AddressDoctor is headquartered in Maxdorf, Ludwigshafen, Germany.
Informatica Corporation
Deborah Wiltshire
+1 650 385 5360
Mobile: +1 650 862 8186
Ogilvy PR
David Friedman
+1 303 634 2674
infaopr@ogilvypr.com
Copyright © 2009 GlobeNewswire. All rights reserved. Redistribution of this content is expressly prohibited without prior written consent. GlobeNewswire makes no claims concerning the accuracy or validity of the information, and shall not be held liable for any errors, delays, omissions or use thereof.